Your fact-checks will appear here
The controversy surrounding Neuralink's preclinical animal testing, including allegations of inadequate transparency and animal welfare concerns.
Elon Musk is the founder and primary backer of Neuralink, a biotech/brain‑computer‑interface company that he has publicly promoted as a platform to treat a range of neurological conditions and to enab...
The documents supplied focus on ’s and its promise—and controversies—around brain implants, not on any medication he may be taking; none of these sources report that Musk is on a or describe his perso...
Neuralink’s animal program has been linked in reporting to a range of adverse events—from procedural errors and deaths in primates to quality-control and record-keeping lapses uncovered by regulators ...
Neuralink began first-in-human, early-feasibility trials in 2024 after FDA clearance and publicly announced its first implant in late January 2024, reporting users can move cursors, play games and ope...
There are no peer‑reviewed clinical trial publications of Neuralink’s implants in human patients in the reporting provided; available evidence about human use comes from company updates, press reports...